Jarurat Care Foundation shared a post on LinkedIn:
“In complex cancers like cholangiocarcinoma, clinical decisions are rarely simple.
Horizon IV – Advancing Conversations in Precision Oncology
An academic initiative by Jarurat Care Foundation focused on strengthening oncology education and collaborative learning.
As treatment strategies evolve with immunotherapy, targeted therapy, biomarker-driven approaches, and radiation integration, clinicians must translate emerging evidence into meaningful, patient-centered decisions. This virtual forum brings together leading global and Indian experts to examine data and apply it to real-world clinical practice critically.
Supported by leading institutions:
- MD Anderson Cancer Center
- Sir H.N. Reliance Foundation Hospital and Research Centre
- ILBS India
- Cholangiocarcinoma Foundation
International Speakers:
- Juan W. Valle
- Eugene Koay
Co-Chairs and Speakers
- Milind Javle
- Sewanti Limaye
- Dr. Shailesh Talati
- Dr. Deepti Sharma
- Nikhil Himthani
Designed for oncology specialists and multidisciplinary cancer care teams seeking high-level clinical exchange and evidence-based discussion.
28 February 2026
7:30 PM – 9:00 PM (IST)
Online | Zoom
Because progress in cancer care happens when research, expertise, and real-world practice align.”
Other articles featuring Jarurat Care Foundation on OncoDaily.
